Notice about cookies

Close

This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy. By clicking Accept below or continuing to use this website (including closing this message), you confirm that you have read and consent to our use of cookies as detailed in our Cookie Policy.

Accept

UCB's Global Corporate Website
Welcome to UCB in the United States

Categories

Archives

Jan

30

Collaboration with Duke University Focuses on Health Equity for Adolescents in Uganda

Read More Share:linkedin| twitter| email

Jan

20

Employee Spotlight: Ian Crassweller – Leading and Evolving Through Change

Read More Share:linkedin| twitter| email

Jan

18

Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis

Read More Share:linkedin| twitter| email

Jan

17

5 U.S. Organizations Receive Support from UCB Community Health Fund

Read More Share:linkedin| twitter| email

Jan

13

Patient-first: UCB is there to listen to patients, to not only learn more about them but also from them

Read More Share:linkedin| twitter| email

Jan

06

UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review

Read More Share:linkedin| twitter| email

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)